Knowledge, attitudes, and practices regarding hantavirus disease and acceptance of a vaccine trial in rural communities of southern Chile
Andes hantavirus cardiopulmonary syndrome, transmitted by Oligoryzomys longicaudatus, has no approved treatment, a case fatality rate of 35%, and documented person-to-person transmission. An Andes vaccine, highly needed for prevention, is in development. We aimed to evaluate knowledge, attitudes and...
Saved in:
Main Authors: | Francisca Valdivieso (Author), Claudia Gonzalez (Author), Manuel Najera (Author), Andrea Olea (Author), Analia Cuiza (Author), Ximena Aguilera (Author), Gregory Mertz (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2017-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Modeling to predict cases of hantavirus pulmonary syndrome in Chile.
by: Elaine O Nsoesie, et al.
Published: (2014) -
Seroprevalencia de hantavirus en roedores y casos humanos en el sur de la Argentina Hantavirus seroprevalence in rodents and human cases in southern Argentina
by: Edmundo Larrieu, et al.
Published: (2003) -
Hantavirus and criminality: disease and family
by: Ana Cláudia Pereira Terças Trettel, et al.
Published: (2020) -
Prevalence of caries and social classes in a group of children under 6 years old in southern Chile
by: Gloria Analia González Nieto
Published: (2020) -
Hantavirus Infection: a review and global update
by: Zhenqiang Bi, Pierre B.H. Formenty, Cathy E. Roth
Published: (2008)